Latest Breaking News On - சிங்கப்பூர் ஆரோக்கியம் அறிவியல் அதிகாரம் - Page 16 : comparemela.com
SIA delivers first shipment of Moderna Covid-19 vaccines to Singapore
theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.
AMTH provides RM2 M worth Alpha ventilators to hospitals in Malaysia
biospectrumasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumasia.com Daily Mail and Mail on Sunday newspapers.
Telehealth Ventilators Worth More Than RM2 Million to be Donated to Malaysian Hospitals to Treat COVID-19 Patients in Intensive Care
asiaone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaone.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Singapore Health Sciences Authority (HSA) Approves Interim Authorization of COVID-19 Vaccine Moderna For Use
February 3, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 3, 2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Singapore Health Sciences Authority (HSA) has approved the interim authorization of its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under the Pandemic Special Access Route (PSAR).
ADVERTISEMENT
“Today’s authorization is another important step in the global fight against COVID-19,” said Stéphane Bancel, Chief Executive Officer of Moderna. “I want to thank the Singapore Ministry of Health and the HSA for their collaboration and for the confidence they have demonstrated in COVID-19 Vaccine Moderna with this decision.”
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update
Bloomberg 2/3/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021.
(Bloomberg) AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn.
GlaxoSmithKline Plc agreed to work with CureVac NV to help boost production of its experimental vaccine and improve the shot to help protect against multiple variants.